Please use this identifier to cite or link to this item: https://repositorio.uca.edu.ar/handle/123456789/14225
DC FieldValueLanguage
dc.contributor.authorRoldán Deamicis, Agustinaes
dc.contributor.authorAlonso, Elianaes
dc.contributor.authorBrie, Belénes
dc.contributor.authorBraico, Diego Aguileraes
dc.contributor.authorBalogh, Gabriela Andreaes
dc.date.accessioned2022-06-22T12:43:47Z-
dc.date.available2022-06-22T12:43:47Z-
dc.date.issued2016-
dc.identifier.citationRoldán Deamicis, A. et al. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice [en línea]. Cancer Medicine. 2016, 5(9):2427–2441 doi:10.1002/cam4.744 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14225es
dc.identifier.issn2045-7634-
dc.identifier.urihttps://repositorio.uca.edu.ar/handle/123456789/14225-
dc.description.abstractAbstract: The understanding of the molecular mechanisms of the immune tolerance induced by the tumoral microenvironment is fundamental to prevent cancer development or to treat cancer patients using immunotherapy. Actually, there are investigations about "addressed-drugs" against cancer cells without affecting normal cells. It could be ideal to find selective and specific compounds that only recognize and destroy tumor cells without damaging the host normal cells. For thousands of years, mushrooms have been used for medicinal purposes because of their curative properties. D-Fraction, an extract of Maitake (from the edible Grifola frondosa mushroom), rich in β-glucans, exert notable effects in the immune system. Until now, some published articles suggest that Maitake D-Fraction could have anti-tumoral activity, prevent oncogenesis and metastasis in some tumor types. However, there are no clear data about Maitake D-Fraction action on breast cancer prevention and its exact molecular mechanisms are not yet elucidated. The experiments were performed employing 25 female BALBc mice that were treated with and without Maitake D-Fraction Pro4X or Maitake Standard for 15 days by daily intraperitoneal injection. After treatment period, all mice were implanted with murine tumor cells LM3 to induce mammary tumorigenesis. Animals were checked weekly and killed after 46 days of LM3 transplant; percentage of cancer prevention, rate of tumor growing, and overall survival were determined. Under dissection, the internal organs were evaluated histologically and genetically by RT-PCR. We found that 5 mg/kg per day of Maitake D-Fraction Pro4X, administered dairy during 15 days to BALBc mice was able to block more than 60% breast cancer development. However, Maitake Standard prevents oncogenesis in 26% to respect control. In this work, we found that Maitake D-Fraction Pro4X, administered to BALBc mice, prevents breast carcinogenesis, block tumor invasiveness, reduce angiogenesis, and increase overall survival.es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherWileyes
dc.rightsAcceso abierto*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.sourceCancer Medicine. 2016, 5(9):2427–2441es
dc.subjectCANCER DE MAMAes
dc.subjectCARCINOGENESISes
dc.subjectPREVENCION DE ENFERMEDADESes
dc.subjectMaitake Pro4Xes
dc.titleMaitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc micees
dc.typeArtículoes
dc.identifier.doi10.1002/cam4.744-
dc.identifier.pmid27401257-
uca.disciplinaMEDICINAes
uca.issnrd1es
uca.affiliationFil: Roldán Deamicis, Agustina. Pontificia Universidad Católica Argentina. Facultad de Ciencias Medicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Roldán Deamicis, Agustina. Consejo Nacional de Investigaciones Científica y Técnicas; Argentinaes
uca.affiliationFil: Alonso, Eliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Recursos Naturales Renovables de la Zona Semiárida. Laboratorio de Hongos Comestibles y Medicinales; Argentinaes
uca.affiliationFil: Brie, Belén. Pontificia Universidad Católica Argentina. Facultad de Ciencias Medicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Brie, Belén. Consejo Nacional de Investigaciones Científica y Técnicas; Argentinaes
uca.affiliationFil: Braico, Diego Aguilera. Pontificia Universidad Católica Argentina. Facultad de Ciencias Medicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Braico, Diego Aguilera. Consejo Nacional de Investigaciones Científica y Técnicas; Argentinaes
uca.affiliationFil: Balogh, Gabriela Andrea. Pontificia Universidad Católica Argentina. Facultad de Ciencias Medicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Balogh, Gabriela Andrea. Consejo Nacional de Investigaciones Científica y Técnicas; Argentinaes
uca.versionpublishedVersiones
item.languageiso639-1en-
item.grantfulltextopen-
item.fulltextWith Fulltext-
Appears in Collections:Artículos
Files in This Item:
File Description SizeFormat
maitake-pro4X-anti-cancer.pdf1,08 MBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

142
checked on Apr 27, 2024

Download(s)

40
checked on Apr 27, 2024

Google ScholarTM

Check


Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons